Literature DB >> 20978325

Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer--indications for anti-TNF-α agents in cancer treatment.

M Grimm1, M Lazariotou, S Kircher, A Höfelmayr, C T Germer, B H A von Rahden, A M Waaga-Gasser, M Gasser.   

Abstract

INTRODUCTION: The progressive growth of malignancies is accompanied by a decline in the immune response through mechanisms which are poorly understood. Apoptosis and induction of inflammation by tumor released cytokines as tumor escape mechanisms have been proposed to play an important role in colorectal carcinogenesis.
METHODS: Expression of Tumor necrosis factor-alpha (TNF-α) was analyzed in colorectal cancer specimen and the cancer cell line HT-29 by immunohistochemistry and RT-PCR. TNF-α expression on protein and mRNA level were correlated with clinical characteristics and impact on survival. TNFR-1 was co-labelled with TNF-α and CD8+ cytotoxic T cells in immunofluorescence double staining experiments.
RESULTS: 94% (n=98/104) of the patients with CRC expressed TNF-α. High TNF-α expression was significantly associated with positive lymph node stage and recurrence of the tumor. Multivariate analysis revealed high TNF-α expression as an independent prognostic factor. Immunohistochemistry was correlated with RT-PCR results (τ=0.794). Immunofluorescence double staining experiments revealed increased TNFR-1 expression by CD8+ cells.
CONCLUSIONS: TNF-α expression by tumor cells may be an efficient immunological escape mechanism by inflammation-enhanced metastases and probably by induction of apoptosis in tumor-infiltrating CD8+ immune cells resulting in a down regulation of the tumoral immune response. Our data support the role of tumor-derived TNF-α expression as an important promoter of tumoral immune escape mechanisms and malignant progression, and suggest that analysis on either protein (immunohistochemistry) or RNA level (RT-PCR) can be used effectively in this respect. Targeting TNF-α may be a promising option, especially in cases with high TNF-α expression and positive lymph node metastases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978325      PMCID: PMC4605536          DOI: 10.3233/ACP-CLO-2010-0539

Source DB:  PubMed          Journal:  Anal Cell Pathol (Amst)        ISSN: 2210-7177            Impact factor:   2.916


  9 in total

1.  Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients.

Authors:  Betsy Annel González-Quezada; Uriel Francisco Santana-Bejarano; Alfredo Corona-Rivera; Helia Judith Pimentel-Gutiérrez; Rocío Silva-Cruz; Citlalli Ortega-De-la-Torre; Ramón Franco-Topete; Karina Franco-Topete; Manuel Willebaldo Centeno-Flores; Víctor Manuel Maciel-Gutiérrez; Jorge Román Corona-Rivera; Juan Armendáriz-Borunda; Lucina Bobadilla-Morales
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

2.  Circulating nuclear factor-kappa B mediates cancer-associated inflammation in human breast and colon cancer.

Authors:  Kundaktepe Berrin Papila; Volkan Sozer; Kocael Pinar Cigdem; Sinem Durmus; Dilara Kurtulus; Cigdem Papila; Remise Gelisgen; Hafize Uzun
Journal:  J Med Biochem       Date:  2021-03-12       Impact factor: 3.402

3.  Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha.

Authors:  Noyko Stanilov; Lyuba Miteva; Zlatka Dobreva; Spaska Stanilova
Journal:  Biotechnol Biotechnol Equip       Date:  2014-10-29       Impact factor: 1.632

4.  A trial sequential meta-analysis of TNF-α -308G>A (rs800629) gene polymorphism and susceptibility to colorectal cancer.

Authors:  Raju K Mandal; Munawwar Ali Khan; Arif Hussain; Naseem Akhter; Arshad Jawed; Sajad A Dar; Mohd Wahid; Aditya K Panda; Mohtashim Lohani; Bhartendu N Mishra; Shafiul Haque
Journal:  Biosci Rep       Date:  2019-01-15       Impact factor: 3.840

Review 5.  Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.

Authors:  María Florencia Mercogliano; Sofía Bruni; Florencia Mauro; Patricia Virginia Elizalde; Roxana Schillaci
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

6.  Establishment of In Vitro and In Vivo Anticolorectal Cancer Efficacy of Lithocholic Acid-Based Imidazolium Salts.

Authors:  Diana Sawicka; Agnieszka Hryniewicka; Sylwia Gohal; Anna Sadowska; Anna Pryczynicz; Katarzyna Guzińska-Ustymowicz; Emilia Sokołowska; Jacek W Morzycki; Halina Car
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

7.  Functional promoter -308G>A variant in tumor necrosis factor α gene is associated with risk and progression of gastric cancer in a Chinese population.

Authors:  Yan Hong; Zhijun Ge; Changrui Jing; Jun Shi; Xiao Dong; Fengying Zhou; Meilin Wang; Zhengdong Zhang; Weida Gong
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

8.  Effects of Tumor Necrosis Factor-α on Morphology and Mechanical Properties of HCT116 Human Colon Cancer Cells Investigated by Atomic Force Microscopy.

Authors:  Huiqing Liu; Nan Wang; Zhe Zhang; Hongda Wang; Jun Du; Jilin Tang
Journal:  Scanning       Date:  2017-06-21       Impact factor: 1.932

9.  Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer.

Authors:  Lanlan Huang; Xiaoyan Wang; Chuangyu Wen; Xiangling Yang; Minmin Song; Junxiong Chen; Chenliang Wang; Bo Zhang; Lei Wang; Aikichi Iwamoto; Jianping Wang; Huanliang Liu
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.